Amazon invests $5 billion in Anthropic for AI

This week, investments in the technology sector were marked by significant amounts, although only half of the ten largest funding rounds exceeded the $100 million threshold. This situation is somewhat unusual during a period when mega-fundings have become commonplace. However, substantial sums have been committed, notably by Amazon in partnership with Anthropic.

Amazon and Anthropic: a Strategic Partnership

Anthropic, a major player in artificial intelligence, announced a $5 billion investment from Amazon. This funding is part of a partnership that could see Amazon invest up to an additional $20 billion in the future. Previously, Amazon had already invested $8 billion in this San Francisco-based company. This new commitment also includes a partnership for the training and deployment of Anthropic's AI assistant, Claude.

Innovations in Autonomy and Biotechnology

Reliable Robotics, a company specializing in the development of autonomous aircraft systems, raised $160 million in a new funding round led by Nimble Partners. Based in Mountain View, California, this 9-year-old company markets its technology for commercial and defense aviation.

Ray Therapeutics, a San Diego biotech startup focused on vision restoration therapies, secured $125 million in a Series B funding round led by Janus Henderson Investors. Founded in 2021, Ray has raised a total of $247 million in venture capital and grants to date, according to Crunchbase data.

Other Notable Fundings

Omni, a developer of an AI-enabled analytics platform, closed $120 million in a Series C funding round led by Iconiq Growth. This funding set a valuation of $1.5 billion for this 4-year-old company based in San Francisco.

Tortugas Neuroscience, a biotech startup focused on neurology and based in Framingham, Massachusetts, raised $106 million in a Series A funding round. Founding investor Cure Ventures co-led the round with The Column Group and AN Venture Partners.

AcuityMD, an AI-enabled data and research platform for medtech industry clients, obtained $80 million in a Series C investment. StepStone Group led the funding for this 7-year-old company based in Boston.

OpenAI, based in San Francisco, saw Robinhood Ventures purchase $75 million in common stock. The shares are held by Robinhood Ventures Fund I, a publicly traded fund that offers investors exposure to a selected portfolio of private companies.

Orkes, a developer of an AI-enabled workflow orchestration platform, secured $60 million in a Series B funding round. AVP led the funding for this 5-year-old startup based in Silicon Valley.

Courier Health, a developer of tools to enhance the experience of patients with chronic or rare diseases, closed $50 million in a Series B funding round. Oak HC/FT led the funding for this New York-based company.

Finally, Serif Biomedicines, a biotech startup based in Cambridge, Massachusetts, focused on modified DNA as a new class of drugs, launched its operations with $50 million in initial funding from Flagship Pioneering.

These fundings were tracked in the Crunchbase database, covering the period from April 18 to April 24. While most of the announced rounds are represented, there may be a slight time lag, as some rounds are reported late in the week.